VIPR1 and hepatocellular carcinoma: Multivariate assays demonstrated that VIPR1 could be used as an independent prognostic factor for HCC (P < 0.05), while other diagnostic genes could not be used as independent prognostic factors for HCC (Figures 8(a)–8(e)).